We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHIM
7201
DELISTED
Global X MSCI China Materials ETF
CHIM
$12K ﹤0.01%
+703
New +$10.6K
TAT
7202
DELISTED
TransAtlantic Petroleum LTD.
TAT
$12K ﹤0.01%
24,177
+16,681
+223% +$7.59K
VVUS
7203
DELISTED
Vivus Inc
VVUS
$12K ﹤0.01%
4,289
+3,793
+765% +$12.1K
VRML
7204
DELISTED
Vermillion, Inc.
VRML
$12K ﹤0.01%
+14,552
New +$9.58K
AMS icon
7205
American Shared Hospital Services
AMS
$9.67M
$11K ﹤0.01%
4,555
+2,321
+104% +$5.74K
APM
7206
DELISTED
Aptorum Group
APM
$11K ﹤0.01%
71
-81
-53% -$12.6K
ATER icon
7207
Aterian
ATER
$5.02M
$11K ﹤0.01%
152
+6
+4% +$430
BCLI
7208
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$11K ﹤0.01%
167
CCM
7209
Concord Medical Services
CCM
$21.5M
$11K ﹤0.01%
417
+1
+0.2% +$26
COHU icon
7210
Cohu
COHU
$2.45B
$11K ﹤0.01%
496
-78
-14% -$1.4K
DGT icon
7211
State Street SPDR Global Dow ETF
DGT
$624M
$11K ﹤0.01%
121
-327
-73% -$28.2K
DXR icon
7212
Daxor
DXR
$61.2M
$11K ﹤0.01%
+1,155
New +$10.9K
FDEV icon
7213
Fidelity International Multifactor ETF
FDEV
$289M
$11K ﹤0.01%
+406
New +$10.6K
HDG icon
7214
ProShares Hedge Replication ETF
HDG
$22.1M
$11K ﹤0.01%
+240
New +$11K
IMNN icon
7215
Imunon
IMNN
$6.64M
$11K ﹤0.01%
34
+14
+70% +$4.25K
IZEA icon
7216
IZEA Worldwide
IZEA
$59M
$11K ﹤0.01%
11,616
+5,704
+96% +$6K
OPLN
7217
PUT
Openlane
OPLN
$4.62B
$11K ﹤0.01%
+500
New +$11.4K
LPRO
7218
DELISTED
Open Lending Corp
LPRO
$11K ﹤0.01%
1,000
MAGA icon
7219
Truth Social America First ETF
MAGA
$31.4M
$11K ﹤0.01%
369
-1,848
-83% -$52K
MVIS icon
7220
Microvision
MVIS
$76.1M
$11K ﹤0.01%
1,040
+1,014
+3,900% +$11.1K
SDEV
7221
Stablecoin Development Corp
SDEV
$52.5M
$11K ﹤0.01%
+3
New +$11K
NHTC icon
7222
Natural Health Trends
NHTC
$14.5M
$11K ﹤0.01%
2,101
-2,144
-51% -$13.7K
PED icon
7223
PEDEVCO
PED
$142M
$11K ﹤0.01%
+336
New +$9.9K
QDIV icon
7224
Global X S&P 500 Quality Dividend ETF
QDIV
$30.4M
$11K ﹤0.01%
404
-14
-3% -$365
SRS icon
7225
ProShares UltraShort Real Estate
SRS
$15.5M
$11K ﹤0.01%
77
-59
-43% -$9.01K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.